Catalepsy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
15
|
|
0.320 |
None |
1.000 |
2 |
|
1998 |
2018 |
Dystonia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
86
|
61
|
0.500 |
None |
1.000 |
1 |
6
|
1989 |
2019 |
Lewy Body Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
22
|
16
|
0.330 |
None |
0.750 |
1 |
|
2006 |
2019 |
Mental deficiency
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
139
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Pheochromocytoma, Extra-Adrenal
|
disease |
Neoplasms
|
Neoplastic Process
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Dyskinesia, Drug-Induced
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
15
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Recurrent depression
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
9
|
|
0.310 |
None |
1.000 |
1 |
|
1991 |
1991 |
Dystonia, Diurnal
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
17
|
|
0.320 |
None |
1.000 |
1 |
|
1989 |
2004 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
507
|
203
|
0.310 |
None |
1.000 |
1 |
|
2012 |
2017 |
Brain Diseases
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
25
|
|
0.300 |
None |
1.000 |
1 |
|
1994 |
1994 |
Hyperkinesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
32
|
2
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Heart Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
46
|
1
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
190
|
233
|
0.580 |
None |
0.900 |
1 |
|
1998 |
2017 |
Dystonia, Paroxysmal
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
18
|
4
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Pheochromocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
19
|
149
|
0.400 |
None |
1.000 |
1 |
|
1985 |
2016 |
Parkinson Disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
85
|
321
|
0.600 |
None |
0.979 |
1 |
|
1989 |
2020 |
Dyskinesia, Medication-Induced
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
15
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Dystonia, Limb
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
17
|
9
|
0.400 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hyperkinesia, Generalized
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
32
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
47
|
166
|
0.400 |
None |
0.950 |
1 |
|
1989 |
2018 |
Encephalopathies
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
27
|
|
0.350 |
None |
1.000 |
1 |
|
1994 |
2019 |
Nerve Degeneration
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
83
|
17
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Mental Retardation, Psychosocial
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
139
|
2
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Profound Mental Retardation
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
139
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Segawa syndrome
|
disease |
|
Disease or Syndrome
|
1
|
|
0.350 |
None |
1.000 |
1 |
|
1995 |
2019 |